Repository logo

Modulation of immune responses on mucosal surfaces through vaccination and dietary intervention

dc.contributor.authorHenderson, Angela J., author
dc.contributor.authorDow, Steven, advisor
dc.contributor.authorSchenkel, Alan, committee member
dc.contributor.authorBiller, Barbara, committee member
dc.contributor.authorGonzalez-Juarrero, Mercedes, committee member
dc.description.abstractNumerous pathogenic organisms enter the body at the mucosal surfaces and therefore the mucosal immune response must function as the first line of defense. The ability of the body to induce protective immune responses on the mucosal surfaces is a powerful strategy for the prevention of disease. Therefore, understanding the mechanism of induction associated with protection is critical if there is to be improvement in current treatments. In these studies, the use of vaccination and diet were investigated as potential strategies for the induction of potent immune responses on the mucosal surfaces. The principle of vaccination has been used successfully for centuries. However, there is still a great need for the development of vaccines against mucosal pathogens such HIV, TB, and newly emerging pathogens. The primary way to improve mucosal vaccination is through the use of a potent vaccine adjuvant. The first part of this project focuses on the use of cationic-liposome plasmid DNA complexes (CLDC) as a mucosal vaccine adjuvant for enhancing the immune response to both particulate and soluble antigens. In these studies, intranasal vaccination using CLDC resulted in a balanced humoral and cellular immune response capable of protecting against a lethal pulmonary bacterial challenge. We found that mucosal immunization with CLDC adjuvant resulted in the increase in the pro-inflammatory cytokines IL-6 and IFN-γ. Also, cellular immune responses were shown to be dependent on MyD88 signaling. Finally, resident airway myeloid dendritic cells (DC) efficiently phagocytosed the CLDC adjuvant and efficiently trafficked the associated antigen to the draining lymph node. Therefore the effectiveness of CLDC as a mucosal vaccine adjuvant appears to depend on strong cytokine induction and efficient antigen presenting cell activation and migration. In a similar manner, dietary modulation has been shown to significantly impact the intestinal immune environment and has only recently begun to be investigated. It represents a novel approach for enhancing protective responses against pathogens and inflammatory diseases. The focus of the second part of this study is the ability of dietary rice bran to modulate the mucosal immune response as a potential mechanism to prevent disease. We found that a diet containing 10% rice bran resulted in an increase in local IgA concentrations and surface expression of IgA on mucosal B cells. Also, dietary rice bran induced a significant increase in myeloid dendritic cells residing in the lamina propria and mesenteric lymph nodes, and increased the colonization of native Lactobacillus, a beneficial gut microorganism known for its ability to positively influence the mucosal immune system. This work has increased our knowledge of the impact of vaccination and dietary modulation for the protection of the mucosal surfaces. More specifically, these findings have revealed that CLDC is a potent vaccine adjuvant and that incorporating rice bran in a balanced diet can augment the mucosal immune environment.
dc.format.mediumborn digital
dc.format.mediumdoctoral dissertations
dc.publisherColorado State University. Libraries
dc.rightsCopyright and other restrictions may apply. User is responsible for compliance with all applicable laws. For information about copyright law, please see
dc.subjectdendritic cell
dc.subjectrice bran
dc.subjectinnate immunity
dc.titleModulation of immune responses on mucosal surfaces through vaccination and dietary intervention
dcterms.rights.dplaThis Item is protected by copyright and/or related rights ( You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s)., Immunology, and Pathology State University of Philosophy (Ph.D.)


Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
5.02 MB
Adobe Portable Document Format